Melatonin and its physiological and therapeutic properties

Pharmacy World and Science

Volumn 20, Issue 1, 1998, Pages 18-27

  Nowak, J Z ^a   Zawilska, J B ^b  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Circadian rhythm; Circadian rhythm sleep disorders; Free radicals; Melatonin; Pineal gland; Seasonal reproduction; Serotonin N acetyltransferase

Indexed keywords

FREE RADICAL; MELATONIN; MELATONIN RECEPTOR; SEROTONIN N ACETYLTRANSFERASE; TRYPTOPHAN HYDROXYLASE;

ADVANCED CANCER; AGING; ALZHEIMER DISEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONFUSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; FATIGUE; HEADACHE; HUMAN; HYPOTHERMIA; INSOMNIA; NAUSEA; ORAL DRUG ADMINISTRATION; PINEAL GLAND FUNCTION; RECEPTOR DENSITY; REVIEW; SLEEP DISORDER; VERTIGO;

ANIMALS; CIRCADIAN RHYTHM; HUMANS; LIGHT; MELATONIN; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN;

EID: 0031942551     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008688724058     Document Type: Review

References (118)

1. Poeggeler B, Balzer I, Harderland R, Lerchl A. Pineal hormone melatonin oscillates also in the dinoflagellate Gonyaulaxpolyedra. Naturwissenschaften 1991;78:268-9.
2. Vivien-Roels B, Pevet P. Melatonin: presence and formation in invertebrates. Experientia 1993;49:642-7.
3. Binkley S (ed.). The Pineal: Endocrine and Nonendocrine Function. Englewood Cliffs: Prentice Hall, 1988.
4. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991;12:151-80.
5. Arendt J (ed.). Melatonin and the Mammalian Pineal Gland. London: Chapman & Hall, 1995.
6. Hattori A, Migitaka H, ligo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJ. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Molec Biol Int 1995;35:627-34.
7. Zawilska JB, Nowak JZ. Regulatory mechanisms in melatonin biosynthesis in retina. Neurochem Int 1992;20:23-36.
8. Huether G. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 1993;49:665-70.
9. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal factor that lightens melanocytes. J Am Chem Soc 1958;80:2587.
10. Axelrod J. The pineal gland: a neurochemical transducer. Science 1974;184:1341-8.
11. Klein DC, Weller JL. Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltransferase. Science 1970;169:1093-5.
12. Thomas KB, Iuvone PM. Circadian rhythm of tryptophan hydroxylase activity in chicken retina. Cell Molec Neurobiol 1991;11:511-7.
13. Sugden D, Klein DC. Adrenergic stimulation of rat pineal hydroxyindole-O-methyltransferase. Brain Res 1983;265:348-51.
14. Lovenberg W, Jequier E, Sjoerdsma A. Tryptophan hydroxylation: measurement in pineal gland, brainstem and carcinoid tumor. Science 1967;155:217-9.
15. Ehret M, Gobaille S, Cash CD, Mandel P, Maitre M (1987). Regional distribution of rat brain tryptophan hydroxylase apoenzyme determined by enzyme-linked immunoassay. Neurosci Lett 1987;73:71-6.
16. Florez JC, Takahashi JS. Quantitative 2-dimensional gel-electrophoretic analysis of clock-controlling proteins in cultured chick pineal cells-circadian regulation of tryptophan hydroxylase. J Biol Rhythms 1996;11:241-57.
17. Green CB, Besharse JC. Tryptophan hydroxylase expression is regulated by a circadian clock in Xenopus laevis retina. J Neurochem 1994;62:2420-8.
18. Ehret M, Pévet P, Maitre M. Tryptophan hydroxylase synthesis is induced by 3′,5′-cyclic adenosine monophosphate during circadian rhythm in the rat pineal gland. J Neurochem 1991;57:1516-21.
19. Shibuya H. Toru M, Watanabe S. A circadian rhythm of tryptophan hydroxylase in rat pineals. Brain Res 1978;138:364-8.
20. Deguchi T. Physiology and molecular biology of arylamine N-acetyltransferases. Biomed Res 1992;13:231-42.
21. Klein DC, Roseboom PH, Coon SL. New light is shining on the melatonin rhythm enzyme. Trends Endocrinol Metab 1996;7:106-12.
22. Nowak JZ, Zurawska E, Zawilska J. Melatonin and its generating system in vertebrate retina: circadian rhythm, effect of environmental lighting, and interaction with dopamine. Neurochem Int 1989;14:397-406.
23. Coon SL, Mazurek K, Bernard M, Roseboom PH, Klein DC, Rodriguez IR. The human serotonin N-acetyltransferase (EC 2.3.1.87) gene (AANAT): structure, chromosomal localization, and tissue expression. Genomics 1996;34:76-4.
24. Klein DC. The melatonin rhythm-generating system. In: Wetterberg L, ed. Light and Biological Rhythms in Man. Oxford: Pergamon Press, 1993:55.
25. Moore RY. Neural control of the pineal gland. Behav Brain Res 1996;73:125-30.
26. Sudgen D. Melatonin biosynthesis in the mammalian pineal gland. Experientia 1989;45:922-32.
27. Sugden D, Klein DC. Essential role of calcium influx in the adrenergic regulation of cAMP and cGMP in rat pinealocytes. J Biol Chem 1986;261:11608-12.
28. Lane EA, Moss HB. Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J Clin Endocrinol Metab 1985;61:1214-6.
29. Cahill GM, Besharse JC. Retinal melatonin is metabolized within the eye of Xenopus laevis. Proc Natl Acad Sci USA 1989;80:1098-102.
30. Grace MS, Cahill GM, Besharse JC. Melatonin deacetylation: retinal vertebrate class distribution and Xenopus laevis tissue distribution. Brain Res 1991;559:56-63.
31. Reiter RJ. The melatonin message: duration versus coincidence hypotheses. Life Sci 1987;46:2119-31.
32. Reiter RJ. Pineal function during aging: attenuation of the melatonin rhythm and its neurobiological consequences. Acta Neurobiol Exp 1994;54(Suppl.):31-9.
33. Robertson LM, Takahashi JS. Circadian clock in cell culture: I. Oscillation of melatonin release from dissociated chick pineal cells. J Neurosci 1988;8:22-30.
34. Underwood H, Barrett RK, Siopes T. The quail's eye: a biological clock. J Biol Rhythms 1990;5:257-65.
35. 2 dopamine receptors. J Neurosci 1991;11:2959-71.
36. Zawilska JB, Wawrocka M. Chick retina and pineal gland differentially respond to constant light and darkness: in vivo studies on serotonin N-acetyltransferase (NAT) activity and melatonin content. Neurosci Lett 1993;153:21-4.
37. Murakami N, Nakamura H, Nishi R, Marumoto N, Nasu T. Comparison of circadian oscillation of melatonin release in pineal cells of house sparrow, pigeon and Japanese quail using cell perfusion systems. Brain Res 1994;651:209-14.
38. Zatz M, Mullen DA, Moskal JR. Photoendocrine transduction in cultured chick pineal cells: Effects of light, dark, and potassium on the melatonin rhythm. Brain Res 1988;438:199-215.
39. 2-dopamine receptor-mediated regulation of serotonin N-acetyltransferase activity. Neurosci Lett 1992;135:71-4.
40. Cahill GM, Besharse JC. Circadian clock functions localized in Xenopus retinal photoreceptors. Neuron 1993;10:573-7.
41. Klein DC, Moore RY, Reppert SM (eds.). Suprachiasmatic Nucleus, The Mind's Clock. Oxford: Oxford University Press, 1991.
42. Reiter RJ. The mammalian pineal gland as an end organ of the visual system. In: Wetterberg L, ed. Light and Biological Rhythms in Man. Oxford: Pergamon Press 1993;145.
43. Zawilska JB, Jarmak A, Woldan-Tambor A, Nowak JZ. Light-induced suppression of nocturnal serotonin N-acetyltransferase activity in chick pineal gland and retina: a wavelength comparison. J Pineal Res 1995;19:87-92.
44. Zawilska JB. Melatonin as a chemical indicator of environmental light-dark cycle. Acta Neurobiol Exp 1996;56:757-67.
45. Brainard GC, Gaddy JR, Barker FM, Hanifin JP, Rollag MD. Mechanisms in the eye that mediate the biological and therapeutic effects of light in humans. In: Wetterberg L, ed. Light and Biological Rhythms in Man. Oxford: Pergamon Press, 1993;29.
46. Laakso ML, Hatonen T, Stenberg D, Alila A, Smith S. One-hour exposure to moderate illuminance (500 lux) shifts the human melatonin rhythm. J Pineal Res 1993;15:21-6.
47. Boivin DB, Duffy JF, Kronauer RE, Czeisler CA. Dose-response relationships for resetting of human circadian clock by light. Nature 1996;379:540-2.
48. Robertson LM, Takahashi JS. Circadian clock in cell culture: II. In vitro entrainment of melatonin oscillation from dissociated chick pineal cells. J Neurosci 1988;8:22-30.
49. Zawilska JB. Clonidine in vivo mimics the acute suppressive but not the phase-shifting effects of light on the circadian rhythm of serotonin N-acetyltransferase activity in chick pineal gland. J Pineal Res 1994;17:63-8.
50. 4-like dopamine receptor suppresses serotonin N-acetyltransferase activity but does not phase-shift the circadian oscillator in chick retina. Neurosci Lett 1994;179:107-10.
51. Mrosovsky N. Locomotor activity and non-photic influences on circadian clocks. Biol Rev 1996;71:343-72.
52. 1H NMR spectroscopy. Analyt Biochem 1984;142:284-9.
53. Morgan PJ, Berrett P, Howell E, Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994;24:101-46.
54. Ebisawa T, Karne S, Lerner MR, Reppert SM. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 1994;91:6133-7.
55. Reppert SM, Weaver DR, Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron, 1995;13:1177-85.
56. 1b melatonin receptor.
57. Reppert SM, Weaver DR, Cassone VM, Godson C, Kolakowski LF. Melatonin receptors are for the birds: Molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 1995; 15: 1003-15.
58. 1a melatonin receptor. Endocrinology 1995;137:3469-77.
59. Reppert SM, Weaver DR, Godson C. Melatonin receptors step into light: cloning and classification of subtypes. Trends Pharmacol Sci 1996;17:100-2.
60. Dubocovich ML. Pharmacology and function of melatonin receptors. FASEB J 1988;2:2765-73.
61. Copinga S, Tepper PG, Grol CJ, Horn AS, Dubocovich ML. 2-Amido-8-methoxytetralins: A series of nonidolic melatonin-like agents. J Med Chem 1993;36:2891-8.
62. Mathé-Allainmat, Gaudy F, Sicsic S, Dangy-Caye A-L, Shen S, Bremont B, Zohra B, Langois M, Renard P, Delegrange P. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors. J Med Chem 1996;39:3089-95.
63. Martinet L, Guardiola-Lemaitre B, Mocaer E. Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol Biochem Behav 1996;54:713-8.
64. Grassi-Zucconi G, Semprevivo M, Mocaer E, Kristensson K, Bentivoglio M. Melatonin and its new agonist S-20098 restore synchronized sleep fragmented by experimental trypanosome infection in the rat. Brain Res Bull 1996;39:63-8.
65. Rivkess SA, Cassone VM, Weaver DR, Reppert SM. Melatonin receptors in chick brain: characterization and localization. Endocrinology 1989;125:363-8.
66. Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995;16:50-6.
67. Reiter RJ. The melatonin rhythm: both a clock and calendar. Experientia 1993;49:654-64.
68. Lewy AJ, Ahmed S, Jackson JML, Sack RL. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992;9:380-92.
69. Lewy AJ, Ahmed S, Sack RL. Phase shifting the human circadian clock using melatonin. Behav Brain Res 1996;73:131-4.
70. Reiter RJ. The pineal gland and its hormones in the control of reproduction in mammals. Endocrinol Rev 1980;1:109-31.
71. Armstrong M, Redman JR. Melatonin: a chronobiotic with anti-aging properties? Med Hyp 1991;34:300-9.
72. Attenburrow MEJ, Dowling BA, Argent PA, Sharpley AL, Cowen PJ. Melatonin phase advances circadian rhythm. Psychopharmacol 1995;121:503-5.
73. Kräuchi K, Cajochen C, Mori D, Hetsch C, Wirz-Justice A. Evidence for a phase advance in circadian temperature regulation after acute melatonin and a melatonin agonist (S-20098). Sleep Res 1995;24:526.
74. Waldhauser F, Saletu B, Trinchard-Lugan I. Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacol 1990;100:222-6.
75. Tzischinsky O, Lavie P. Melatonin possesses time-dependent hypnotic effect. Sleep 1994;17:638-45.
76. Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993;15:1-12.
77. Dawson D, Armstrong SM. Chronobiotics - drugs that shift rhythms. Pharmacol Therapeut 1996;69:15-36.
78. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD. Delayed sleep phase syndrome response to melatonin. Lancet 1991;337:1121-4.
79. Tzischinsky O, Dagan Y, Lavie P. The effects of melatonin on the timing of sleep in patients with delayed sleep phase syndrome. In: Touitou Y, Arendt J and Pévet P, eds. Melatonin and the Pineal Gland - From Basic Science to Clinical Application. Amsterdam: Excerpta Medica, 1993;351.
80. Armstrong SM. Treatment of sleep disorders by melatonin administration. Adv Pineal Res 1991;6:263-74.
81. Regestein QR, Pavlova M. Treatment of delayed sleep phase syndrome. Gen Hosp Psychiatry 1995;17:335-45.
82. Jan JE, Espezel H, Appleton RE. The treatment of sleep disorders with melatonin. Dev Med Child Neurol 1994;36:97-107.
83. Brown GM. Melatonin in psychiatric and sleep disorders. CNS Drugs 1995;3:209-26.
84. Folkard A, Arendt J, Aldhous M, Kennett H. Melatonin stabilizes sleep onset time in a blind man without entrainment of cortisol or temperature rhythms. Neurosci Lett 1990;113:193-8.
85. Palm L, Blennow G, Wetterberg L. Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy. Ann Neurol 1991;29:336-9.
86. Sack RL, Lewy AJ, Blood ML, Stevenson J, Keith LD. Melatonin administration to blind people: phase advances and entrainment. J Biol Rhythms 1991;6:249-61.
87. Tzischinsky O, Pal I, Epstein R, Dagan Y, Lavie P. The importance of timing in melatonin administration in a blind man. J Pineal Res 1992;12:105-8.
88. Lapierre O, Dumont M. Melatonin treatment of a non-24-hour sleep-wake cycle in a blind retarded child. Biol Psychiatry 1995;38:119-22.
89. Arendt J, Aldhous M, Wright J. Synchronisation of a disturbed sleep-wake cycle in a blind man by melatonin treatment (letter). Lancet 1988;1:772-3.
90. Cavallo A. The pineal gland in human beings: relevance to pediatrics. J Pediatr 1993;123:843-51.
91. Arendt J, Aldhous M, English J, Marks V, Arendt JH. Some effects of jet-lag and their alleviation by melatonin. Ergonomics 1987;30:1379-93.
92. Skene DJ, Aldhous M, Arendt J. Melatonin, jet-lag and the sleep-wake cycle. In Sleep'88. Proceedings of the Ninth European Congress on Sleep Research, Jerusalem 1988. Home J, ed. Stuttgart: Gustav Fischer Verlag, 1989;39.
93. Claustrat B, Brun J, David M, Sassolas G, Chazot G. Melatonin and jet lag: confirmatory result using a simplified protocol. Biol Psychiatry 1992;32:705-11.
94. Arendt J, Deacon S, English J, Hampton S, Morgan L. Melatonin and adjustment to phase shift. J Sleep Res 1995;4,Suppl.2:74-9.
95. Nickeisen T, Lang A, Bergau L. The effect of 6-, 9- and 11-hour time shifts on circadian rhythms: adaptation of sleep parameters and hormonal patterns following the intake of melatonin or placebo. Adv Pineal Res 1991;5:303-6.
96. Folkard S, Arendt J, Clark M. Can melatonin improve shift workers' tolerance of the night shift? Some preliminary findings. Chronobiol Int 1993;10:315-20.
97. Skene DJ, Deacon S, Arendt J. Use of melatonin in circadian rhythm disorders and following phase shifts. Acta Neurobiol Exp 1996;56:359-62.
98. Haimov I, Lavie P. Potential of melatonin replacement therapy in older patients with sleep disorders. Drugs Aging 1995;2:75-8.
99. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18:598-603.
100. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995;346:541-4.
101. Etzioni A, Luboshitsky R, Tiosano D, Ben-Harush M, Goldsher D, Lavie P. Melatonin replacement corrects sleep disturbances in a child with pineal tumor. Neurol 1996;46:261-3.
102. Singer C, McArthur A, Hughes R, Jackon J, Moffit M, Sack R, Lewy AJ. Melatonin administration and sleep in the elderly. In: Hypothalamic Integration of Circadian Rhythm, 19th International Summer School of Brain Research, Amsterdam, 1995;103.
103. Dollins AB, Zhdanova IV, Wurtman JR, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 1994;91:1824-8.
104. Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DL. Sleep-inducing effect of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57;552-8.
105. Attenburrow MEJ, Cowen PJ, Sharpley AL. Low dose of melatonin improves sleep in healthy middle-aged subjects. Psychopharmacol 1996;126:179-81.
106. Wirz-Justice A, Armstrong SM. Melatonin: nature's soporific? J Sleep Res 1996;5:137-41.
107. Brzezinski A. Melatonin in humans. New England J Med 1997;336:186-95.
108. Webb SM, Puig-Domingo M. Role of melatonin in health and disease. Clin Endocrinol 1995;42:221-34.
109. Reiter RJ, Melchiori D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuna-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11.
110. Pierrefiche G, Laborit H. Oxygen free radicals, melatonin, and aging. Exp Gerontology 1995;30:213-27.
111. Blask DE. Melatonin in oncology. In: Yu HS and Reiter RJ, eds. Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications. Boca Raton: CRC Press, 1993;447.
112. Maestroni GJM, Conti A. Melatonin and the immune system. In: Touitou Y, Arendt J and Pévet P, eds. Melatonin and the Pineal Gland - From Basic Science to Clinical Application. Amsterdam: Excerpta Medica, 1993:295.
113. Pieri C, Marra M, Moronin F, Recchioni R, Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55:271-6.
114. Giusti P, Guselle M, Lipartiti M, Milani D, Zhu W, Vicini S, Manev H. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp Neurol 1995;131:39-46.
115. Lissoni P, Barni S, Cattaneo G, Tancini G, Esposti G, Fraschini F. Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology 1991;48:448-50.
116. Lissoni P, Barni S, Brivio F, Rossini F, Fumagalli L, Ardizzoia A, Tancini G. A biological study on the efficacy of low dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia. Oncology 1995;52:360-2.
117. Lissoni P, Meregalli S, Nosetto L, Barni S, Tancini G, Fossati V, Maestroni G. Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology 1996;53:43-6.
118. Nagtegaal S, Smits M, Swart W, van der Meer G, Kerkhof G. Melatonin secretion and coronary heart disease (letter). Lancet 1995;346:1299.